Emerald Development Managers — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Lifesproutbiolifesproutbio.comFeb 2018

LifeSprout develops tissue-engineering products for aesthetic and regenerative medicine, designed to restore soft tissue losses caused by aging, cancer, and metabolic disease.

BiotechHealthtechMedical Devices

Hai-Quan Mao(Executive Officer, Promoter)Sashank Reddy(Executive Officer, Director, Promoter)Gregory Sieczkiewicz(Executive Officer, Director, Promoter)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.